One of the strongest performing NBFC's + Pharma companies where both businesses are growing.
Many doubted the DHFL acquisition but DHFL always was a solid company and now they have it without having much interest dues to make. The company reported a Q1 profit of 300+ cr which will supplement their income.
Long above 2790 and again above 2860 for targets of 3200.
After first purchase SL can be around 2675.
Many doubted the DHFL acquisition but DHFL always was a solid company and now they have it without having much interest dues to make. The company reported a Q1 profit of 300+ cr which will supplement their income.
Long above 2790 and again above 2860 for targets of 3200.
After first purchase SL can be around 2675.